Hält derzeit eine Position bei Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
President, Chief Operating Officer, Director | Syndax Pharmaceuticals Inc | 4. Juli 2019 - |
President, Chief Operating Officer | Syndax Pharmaceuticals Inc | 5. Mai 2015 - 4. Juli 2019 |
Executive Vice President and Chief Operating Officer | Mersana Therapeutics Inc | None - |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-02-08 | 2023-02-06 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
5.959
-25.2%
27,64164.697 USD |
5.959 -25.2% | 27,64 | 164.697 USD | |
2022-11-10 | 2022-11-08 |
CTI Biopharma Corp
(CTIC)
|
GV Geplanter Verkauf |
4.500
-100.0%
5,7025.660 USD |
4.500 -100.0% | 5,70 | 25.660 USD | |
2022-11-10 | 2022-11-08 |
CTI Biopharma Corp
(CTIC)
|
GV Geplanter Verkauf |
36.942
-89.1%
5,65208.578 USD |
36.942 -89.1% | 5,65 | 208.578 USD | |
2022-11-10 | 2022-11-08 |
CTI Biopharma Corp
(CTIC)
|
GV Geplanter Verkauf |
50.058
-54.7%
5,53276.781 USD |
50.058 -54.7% | 5,53 | 276.781 USD | |
2022-10-07 | 2022-10-06 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
16.231
-47.9%
25,29410.508 USD |
16.231 -47.9% | 25,29 | 410.508 USD | |
2022-10-04 | 2022-10-04 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
1.280
-6.8%
25,0232.026 USD |
1.280 -6.8% | 25,02 | 32.026 USD | |
2022-10-04 | 2022-10-03 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
2.883
-14.0%
25,0172.107 USD |
2.883 -14.0% | 25,01 | 72.107 USD | |
2022-10-04 | 2022-09-30 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
29.606
-62.6%
25,02740.757 USD |
29.606 -62.6% | 25,02 | 740.757 USD | |
2022-07-07 | 2022-07-05 |
CTI Biopharma Corp
(CTIC)
|
GV Geplanter Verkauf |
3.331
-14.2%
6,2320.737 USD |
3.331 -14.2% | 6,23 | 20.737 USD | |
2022-07-07 | 2022-07-05 |
CTI Biopharma Corp
(CTIC)
|
GV Geplanter Verkauf |
27.506
-54.0%
6,14168.895 USD |
27.506 -54.0% | 6,14 | 168.895 USD | |
2022-07-07 | 2022-07-05 |
CTI Biopharma Corp
(CTIC)
|
GV Geplanter Verkauf |
51.963
-50.5%
6,05314.439 USD |
51.963 -50.5% | 6,05 | 314.439 USD | |
2022-07-07 | 2022-07-05 |
CTI Biopharma Corp
(CTIC)
|
GV Geplanter Verkauf |
8.700
-7.8%
5,9851.996 USD |
8.700 -7.8% | 5,98 | 51.996 USD | |
2021-12-20 | 2021-12-20 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
45.000
-71.8%
20,29912.960 USD |
45.000 -71.8% | 20,29 | 912.960 USD | |
2021-12-20 | 2021-12-20 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
16.000
-47.5%
20,29324.608 USD |
16.000 -47.5% | 20,29 | 324.608 USD | |
2021-12-20 | 2021-12-17 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
1.676
-8.7%
19,0231.877 USD |
1.676 -8.7% | 19,02 | 31.877 USD | |
2021-12-20 | 2021-12-16 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
22.715
-56.3%
19,08433.400 USD |
22.715 -56.3% | 19,08 | 433.400 USD | |
2021-12-15 | 2021-12-13 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
34.564
-66.2%
19,05658.555 USD |
34.564 -66.2% | 19,05 | 658.555 USD | |
2021-12-15 | 2021-12-13 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
2.045
-10.4%
19,0538.964 USD |
2.045 -10.4% | 19,05 | 38.964 USD | |
2021-10-27 | 2021-10-26 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
16.296
-48.0%
19,20312.825 USD |
16.296 -48.0% | 19,20 | 312.825 USD | |
2021-10-27 | 2021-10-25 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
44.704
-71.7%
19,13855.335 USD |
44.704 -71.7% | 19,13 | 855.335 USD | |
2021-09-28 | 2021-09-27 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
24.437
-58.1%
19,51476.832 USD |
24.437 -58.1% | 19,51 | 476.832 USD | |
2021-02-03 | 2021-02-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
15.000
-45.9%
20,19302.799 USD |
15.000 -45.9% | 20,19 | 302.799 USD | |
2020-12-03 | 2020-12-01 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
15.000
-45.9%
22,97344.513 USD |
15.000 -45.9% | 22,97 | 344.513 USD | |
2020-11-06 | 2020-11-04 |
Syndax Pharmaceuticals Inc
(SNDX)
|
GV Geplanter Verkauf |
100.000
-85.0%
20,312.031.410 USD |
100.000 -85.0% | 20,31 | 2.031.410 USD |